Text Size

Development of Definitive and Reliable Grading Scales for Meibomian Gland Dysfunction

Arita R., Minoura I., Morishige N., Shirakawa R., Fukuoka S., Asai K., Goto T., Imanaka T., Nakamura M.


  • 2016
  • American Journal of Ophthalmology
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Affiliations

    Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Department of Ophthalmology, Itoh Clinic, Saitama, Japan; Research and Development Division, Santen Pharmaceutical Co Ltd, Osaka, Japan; Department of Ophthalmology, Graduate School of Medicine, Yamaguchi University, Yamaguchi, Japan; Tokyo Kyosai Hospital, Tokyo, Japan

Related Publications

Six-month efficacy and safety of oxymetazoline hydrochloride 0.1% in Japanese patients with acquired blepharoptosis: a phase 3 study

Ishikawa H., Oka K., Inoue H.


Tear Biomarkers of Topical Sirolimus in Meibomian Gland Dysfunction: A Randomized Trial

Zhou L.; Shimizu H.; Togashi Y.; Kirihara T.; Yang Y.; Lam C.T.; Shimada H.; Tong L.


Layer-by-layer tear film measurement in patients with dry eye and meibomian gland dysfunction

Arita R., Takeuchi G., Sasai K., Nakamura M., Akiba M.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022